notebooklm.google.com/notebook/7fc...
AI really takes education to a crazy level, I've uploaded this pdf to NotebookLM website from Google, and it generated this audio track of 2 people discussing the article π«‘
Unleashing power of AI π€
18.11.2024 20:25 β π 4 π 0 π¬ 0 π 0
I'm interested in being added please
18.11.2024 01:44 β π 2 π 0 π¬ 1 π 0
For oncologists based in the UK to share thoughts and discuss cancer treatment paradigm
Inspired by the other great starter packs, UK Oncologists on BlueSky starter pack is up!
Please let me know if youβd like to be added!
go.bsky.app/EfcDXY2
18.11.2024 01:38 β π 5 π 0 π¬ 2 π 0
I'm interested in being added,
please
18.11.2024 01:17 β π 0 π 0 π¬ 0 π 0
Starting a list of oncology related peopl. Please tell me more to add. Or any similar listd go.bsky.app/GKXp9Fy @n8pennell.bsky.social
10.11.2024 21:54 β π 110 π 44 π¬ 81 π 13
#medsky #oncsky #oncmed
18.11.2024 00:34 β π 2 π 0 π¬ 0 π 0
#medsky #oncsky #oncmed
18.11.2024 00:34 β π 2 π 0 π¬ 0 π 0
#lungcancer #oncsky #oncmed #LCSM #lcam
18.11.2024 00:22 β π 0 π 0 π¬ 0 π 0
#lungcancer #oncsky #oncmed #LCSM #lcam
18.11.2024 00:21 β π 0 π 0 π¬ 0 π 0
The intriguing overall survival results of the PRIMA trial
Will this affect our treatment paradigm? π€·ββοΈ
17.11.2024 23:48 β π 3 π 0 π¬ 1 π 0
Excellent summary of Relevant Clinical Trials With Adjuvant and Neoadjuvant Immunotherapy Components in Resectable NSCLC.
Should we adopt peri-operative approach rather than neoadjuvant pathways? π«
17.11.2024 23:39 β π 5 π 0 π¬ 1 π 1
"VTE during NACTx chemotherapy for ovarian cancer"
1 in 5 patients undergoing neoadjuvant chemotherapy diagnosed with VTE.
1 in 9 diagnosed after commencing chemotherapy.
leading to delay to treatment and mortality.
Justifies the consideration of thromboprophylaxis.
Do you use Khorana score!!
17.11.2024 23:30 β π 3 π 1 π¬ 1 π 0
I'm a lung cancer oncologist based in the UK, interested in being added β¨οΈ
17.11.2024 23:08 β π 2 π 0 π¬ 0 π 0
ASCO updated Guideline, Version 2024.2 is now live
Published November 12, 2024
Therapy for Stage IV NonβSmall Cell Lung Cancer With Driver Alterations.
To me, treating uncommon EGFR mutations (G719X, L861Q, S7681) is still an area of great interest.
17.11.2024 23:04 β π 6 π 2 π¬ 1 π 0
Thanks
17.11.2024 22:14 β π 0 π 0 π¬ 0 π 0
I'm an oncologist interested in being added β¨οΈ
17.11.2024 22:08 β π 1 π 0 π¬ 0 π 0
I'm an oncologist interested in being added β¨οΈ
17.11.2024 22:07 β π 0 π 0 π¬ 1 π 0
Assistant Professor at Markey (Comprehensive) Cancer Center. http://eal-metabolab.com. Ex-postdoc (@bensahralab) at Northwestern, Metabolism and signaling lover. Writer. Stockholm alum. ORCID: https://orcid.org/0000-0002-9477-3500
π§ PhD Student @pietraslab in Brain Tumor Biology, Lund University. Interested in #Tumor #Microenvironmentπ©Έ Cancer Survivor from Acute LeukemiaποΈ #APML
The only pan-tumour, MDT, clinically focussed annual meeting on the UK cancer meetings calendar. The meeting runs post ASCO and includes valuable updates and insights from Chicago. The meeting is FREE to all UK cancer HCPs and is CME accredited by RCP.
Clinical Senior Lecturer in Medical Oncology University of Dundee | Honorary NHS Consultant | Research - frailty, geriatric oncology, precision medicine in UGI/HPB cancer.
RETpositive is a patient-driven non-profit dedicated to improving quality of life and outcomes for those with RET-driven cancers through research, education, and advocacy. RETpositive.org
Director of the Duke University Center for Computational and Digital Health Innovation. Alfred Winborne Mordecai and Victoria Stover Mordecai Associate Professor of Biomedical Engineering. Research in HPC and digital twins for health.
Med Onc Doc/Researcher. Former @USUKFulbright @EcatTrack #oncology #glioblastoma π¬π§π©πͺ Chair @onctrainees. @CSO_Scotland Clin Lecturer
BMT, Gene Therapy, & Hematology Physician at Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School | AI, Health Policy, Health Economics, & Ethics research | T.H. Chan Harvard MPH β23 | SGU '15 | Cornell β10
Tea addict and scientist, in that order. Incoming Group Leader, Dept of Oncology, University of Oxford. All views my own.
MD Onc in Brazil. PhD candidate at USP.
Interests in #rstats #cancer #llm #publichealth #healthequity
Anatomical & molecular pathologist, Dept of #neuropath, π§ π¬π§¬ RPA Hospital, Sydney, Australia π¨ | Views my own
Senior clinical fellow in medical oncology in London. Interested in #ClinicalTrials and #BCSM. Founding editor of Oncopaedia. Proud father, husband, and doctor. #OncSky
π munster.me
Christ-follower, people-lover, wife, mom, oncology RN, Clinical Journal of Oncology Nursing Editor, thanks-giver, author, podcast host, The Creating Collective Co-Founder & Chief Vision Officer. Opinions & views are mine alone. www.joniwatson.com #NurseSky
π³πΏMedical Oncologistπ©π»ββοΈSenior lecturer University Otago Wellington/Auckland π©π»βπ« Motherπ€±π» Food enthusiastπ©π»βπ³#MedEd
Childhood Cancer Research Prof | Director Newcastle University Centre for Cancer | Representing myself
-Breast Cancer Researcher
-Academic Director @CUH/UCC Cancer Centre, Cork, IRL
-Director, Cancer Research @UCC & UCC Cancer Trials Group
-Associate Professor @JohnsHopkins, Baltimore, MD
-Views are my own.
Registered #Nurse in #PrimaryCare
BSc Adult Nursing
Level 4 #PersonalTrainer
Star Trek ππ»/ Green Party π/ Fitness
Sussex, UK π¬π§
π³οΈβππ€π¨ββοΈπͺπ»
Views are my own
The Cholangiocarcinoma Foundation is a global 501(c)(3) non-profit organization and our mission is to find a cure and improve the quality of life for cholangiocarcinoma patients.
Postdoc at the Netherlands Cancer Institute. Cancer Modeller. Rat Advocate.
Oncology researcher, immuno-oncology drug development, clinical operations, I run the trials, avid reader, cozy gamer, excellent at trivia, my own iteration of star-stuff, very gay, etc.
π³οΈβππ§Ώπ€·π»βοΈπ¬
